Excess positional mutual information predicts both local and allosteric mutations affecting beta lactamase drug resistance
暂无分享,去创建一个
[1] T. Darden,et al. Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems , 1993 .
[2] G. Jacoby,et al. Extended-spectrum beta-lactamases , 1989, Antimicrobial Agents and Chemotherapy.
[3] F. Baquero,et al. Dramatic Increase in Prevalence of Fecal Carriage of Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae during Nonoutbreak Situations in Spain , 2004, Journal of Clinical Microbiology.
[4] Robert C. Edgar,et al. MUSCLE: multiple sequence alignment with high accuracy and high throughput. , 2004, Nucleic acids research.
[5] Jacqueline C. Hargis,et al. Ligand-Induced Proton Transfer and Low-Barrier Hydrogen Bond Revealed by X-ray Crystallography. , 2015, Journal of the American Chemical Society.
[6] S. Mobashery,et al. The future of the β-lactams. , 2010, Current opinion in microbiology.
[7] R. Bonnet,et al. Novel Cefotaximase (CTX-M-16) with Increased Catalytic Efficiency Due to Substitution Asp-240→Gly , 2001, Antimicrobial Agents and Chemotherapy.
[8] S. Levy,et al. Antibacterial resistance worldwide: causes, challenges and responses , 2004, Nature Medicine.
[9] B. Shoichet,et al. The acylation mechanism of CTX-M beta-lactamase at 0.88 a resolution. , 2007, Journal of the American Chemical Society.
[10] O. Abián,et al. Distant and New Mutations in CTX-M-1 β-Lactamase Affect Cefotaxime Hydrolysis , 2011, Antimicrobial Agents and Chemotherapy.
[11] M. Parrinello,et al. Canonical sampling through velocity rescaling. , 2007, The Journal of chemical physics.
[12] T. Wichelhaus,et al. Integrated Detection of Extended-Spectrum-Beta-Lactam Resistance by DNA Microarray-Based Genotyping of TEM, SHV, and CTX-M Genes , 2009, Journal of Clinical Microbiology.
[13] R. Bonnet,et al. Prediction of the Evolution of Ceftazidime Resistance in Extended-Spectrum β-Lactamase CTX-M-9 , 2006, Antimicrobial Agents and Chemotherapy.
[14] Richard Bonnet,et al. Structure, function, and inhibition along the reaction coordinate of CTX-M beta-lactamases. , 2005, Journal of the American Chemical Society.
[15] Yoshikazu Ishii,et al. Acyl-intermediate Structures of the Extended-spectrum Class A β-Lactamase, Toho-1, in Complex with Cefotaxime, Cephalothin, and Benzylpenicillin* , 2002, The Journal of Biological Chemistry.
[16] J. Cooper,et al. The active site protonation states of perdeuterated Toho‐1 β‐lactamase determined by neutron diffraction support a role for Glu166 as the general base in acylation , 2011, FEBS letters.
[17] M. Karplus,et al. Molecular dynamics and protein function. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[18] N. Woodford,et al. CTX-M: changing the face of ESBLs in Europe. , 2006, The Journal of antimicrobial chemotherapy.
[19] D. M. Perry,et al. Single-disk antibiotic-sensitivity testing of staphylococci; an analysis of technique and results. , 1959, A.M.A. archives of internal medicine.
[20] H. Kamberaj,et al. Extracting the causality of correlated motions from molecular dynamics simulations. , 2009, Biophysical journal.
[21] Peter M. Kasson,et al. GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit , 2013, Bioinform..
[22] W. Sougakoff,et al. The TEM-3 β-lactamase, which hydrolyzes broad-spectrum cephalosporins, is derived from the TEM-2 penicillinase by two amino acid substitutions , 1988 .
[23] P. Nordmann,et al. Biochemical analysis of the ceftazidime-hydrolysing extended-spectrum β-lactamase CTX-M-15 and of its structurally related β-lactamase CTX-M-3 , 2002 .
[24] P. Nordmann,et al. Biochemical analysis of the ceftazidime-hydrolysing extended-spectrum beta-lactamase CTX-M-15 and of its structurally related beta-lactamase CTX-M-3. , 2002, The Journal of antimicrobial chemotherapy.
[25] Vijay S. Pande,et al. A-Site Residues Move Independently from P-Site Residues in all-Atom Molecular Dynamics Simulations of the 70S Bacterial Ribosome , 2012, PloS one.
[26] Benjamin R. Jack,et al. Functional Sites Induce Long-Range Evolutionary Constraints in Enzymes , 2016, PLoS biology.
[27] B. Shoichet,et al. The Acylation Mechanism of CTX-M β-Lactamase at 0.88 Å Resolution , 2007 .
[28] M. Karplus,et al. Method for estimating the configurational entropy of macromolecules , 1981 .
[29] Adrian J Mulholland,et al. High level QM/MM modeling of the formation of the tetrahedral intermediate in the acylation of wild type and K73A mutant TEM-1 class A beta-lactamase. , 2009, The journal of physical chemistry. A.
[30] J. Herrmann,et al. Diversity of CTX-M beta-lactamases and their promoter regions from Enterobacteriaceae isolated in three Parisian hospitals. , 2002, FEMS microbiology letters.
[31] Thomas M. Cover,et al. Elements of Information Theory , 2005 .
[32] Charles L Brooks,et al. Correlated motion and the effect of distal mutations in dihydrofolate reductase , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[33] Sharon Hammes-Schiffer,et al. Effect of mutation on enzyme motion in dihydrofolate reductase. , 2003, Journal of the American Chemical Society.
[34] M. Gazouli,et al. Sequence of the Gene Encoding a Plasmid-Mediated Cefotaxime-Hydrolyzing Class A β-Lactamase (CTX-M-4): Involvement of Serine 237 in Cephalosporin Hydrolysis , 1998, Antimicrobial Agents and Chemotherapy.
[35] Effects of Ser130Gly and Asp240Lys Substitutions in Extended-Spectrum β-Lactamase CTX-M-9 , 2003, Antimicrobial Agents and Chemotherapy.
[36] R. Bonnet,et al. Effect of D240G substitution in a novel ESBL CTX-M-27. , 2003, The Journal of antimicrobial chemotherapy.
[37] G. Bou,et al. Structure-function studies of arginine at position 276 in CTX-M beta-lactamases. , 2008, The Journal of antimicrobial chemotherapy.
[38] Arieh Warshel,et al. Molecular dynamics simulations of biological reactions. , 2002, Accounts of chemical research.
[39] R. Bonomo,et al. Inhibition of class A beta-lactamases by carbapenems: crystallographic observation of two conformations of meropenem in SHV-1. , 2008, Journal of the American Chemical Society.
[40] V. Hornak,et al. Comparison of multiple Amber force fields and development of improved protein backbone parameters , 2006, Proteins.
[41] R. Dror,et al. Improved side-chain torsion potentials for the Amber ff99SB protein force field , 2010, Proteins.
[42] E. Myers,et al. Basic local alignment search tool. , 1990, Journal of molecular biology.
[43] Berk Hess,et al. LINCS: A linear constraint solver for molecular simulations , 1997, J. Comput. Chem..
[44] R. Cantón,et al. The CTX-M β-lactamase pandemic , 2006 .
[45] Oliver F. Lange,et al. Generalized correlation for biomolecular dynamics , 2005, Proteins.
[46] Holger Gohlke,et al. The Amber biomolecular simulation programs , 2005, J. Comput. Chem..
[47] Hua Guo,et al. Antibiotic deactivation by a dizinc beta-lactamase: mechanistic insights from QM/MM and DFT studies. , 2007, Journal of the American Chemical Society.
[48] B. Shoichet,et al. Structure and Dynamics of CTX-M Enzymes Reveal Insights into Substrate Accommodation by Extended-spectrum β-Lactamases , 2008 .
[49] Vijay S Pande,et al. Combining molecular dynamics with bayesian analysis to predict and evaluate ligand-binding mutations in influenza hemagglutinin. , 2009, Journal of the American Chemical Society.
[50] J. Frère,et al. Catalytic properties of class A beta-lactamases: efficiency and diversity. , 1998, The Biochemical journal.
[51] A. Warshel. Electrostatic Origin of the Catalytic Power of Enzymes and the Role of Preorganized Active Sites* , 1998, The Journal of Biological Chemistry.
[52] M. Karplus,et al. Collective motions in proteins: A covariance analysis of atomic fluctuations in molecular dynamics and normal mode simulations , 1991, Proteins.
[53] R. Cantón,et al. CTX-M Enzymes: Origin and Diffusion , 2012, Front. Microbio..